A cytotoxic porphyrin from north pacific brittle star ophiura sarsii

Antonina Klimenko, Robin Huber, Laurence Marcourt, Estelle Chardonnens, Alexey Koval, Yuri S. Khotimchenko, Emerson Ferreira Queiroz*, Jean Luc Wolfender*, Vladimir L. Katanaev*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Triple-negative breast cancer (TNBC) represents the deadliest form of gynecological tumors currently lacking targeted therapies. The ethanol extract of the North Pacific brittle star Ophiura sarsii presented promising anti-TNBC activities. After elimination of the inert material, the active extract was submitted to a bioguided isolation approach using high-resolution semipreparative HPLC-UV, resulting in one-step isolation of an unusual porphyrin derivative possessing strong cytotoxic activity. HRMS and 2D NMR resulted in the structure elucidation of the compound as (3S,4S)-14-Ethyl-9-(hydroxymethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid. Never identified before in Ophiuroidea, porphyrins have found broad applications as photosensitizers in the anticancer photodynamic therapy. The simple isolation of a cytotoxic porphyrin from an abundant brittle star species we describe here may pave the way for novel natural-based developments of targeted anti-cancer therapies.

Original languageEnglish
Article number11
JournalMarine Drugs
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 2021
Externally publishedYes

Keywords

  • Breast cancer
  • Cytotoxicity
  • Ophiura sarsii
  • Photodynamic therapy
  • Porphyrin
  • Targeted therapy

Fingerprint

Dive into the research topics of 'A cytotoxic porphyrin from north pacific brittle star ophiura sarsii'. Together they form a unique fingerprint.

Cite this